You just read:

MAX BioPharma Announces Key Update on its Oxysterol Therapeutics™ Development Program: Publication of Evidence for Oxysterols that Inhibit Hedgehog Signaling, a Tumorigenic Cellular Pathway

News provided by

MAX BioPharma

08 Aug, 2016, 10:40 ET